128 related articles for article (PubMed ID: 8700556)
1. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells.
Huynh DP; Pulst SM
Oncogene; 1996 Jul; 13(1):73-84. PubMed ID: 8700556
[TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
[TBL] [Abstract][Full Text] [Related]
3. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells.
Lutchman M; Rouleau GA
Cancer Res; 1995 Jun; 55(11):2270-4. PubMed ID: 7757975
[TBL] [Abstract][Full Text] [Related]
4. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
Sherman L; Xu HM; Geist RT; Saporito-Irwin S; Howells N; Ponta H; Herrlich P; Gutmann DH
Oncogene; 1997 Nov; 15(20):2505-9. PubMed ID: 9395247
[TBL] [Abstract][Full Text] [Related]
5. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
[TBL] [Abstract][Full Text] [Related]
6. Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.
Huynh DP; Tran TM; Nechiporuk T; Pulst SM
Cell Growth Differ; 1996 Nov; 7(11):1551-61. PubMed ID: 8930405
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromatosis type 2 (NF2)].
Araki N; Takeshima H; Saya H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
[TBL] [Abstract][Full Text] [Related]
8. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
Scoles DR; Yong WH; Qin Y; Wawrowsky K; Pulst SM
Hum Mol Genet; 2006 Apr; 15(7):1059-70. PubMed ID: 16497727
[TBL] [Abstract][Full Text] [Related]
9. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
Shaw RJ; McClatchey AI; Jacks T
Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of Schwann cells from neurofibromatosis type 2 patients.
Rosenbaum C; Kluwe L; Mautner VF; Friedrich RE; Müller HW; Hanemann CO
Neurobiol Dis; 1998 Jul; 5(1):55-64. PubMed ID: 9702788
[TBL] [Abstract][Full Text] [Related]
11. Immunoblotting analysis of schwannomin/merlin in human schwannomas.
Harwalkar JA; Lee JH; Hughes G; Kinney SE; Golubić M
Am J Otol; 1998 Sep; 19(5):654-9. PubMed ID: 9752976
[TBL] [Abstract][Full Text] [Related]
12. [A new tumor suppressor gene responsible for type 2 neurofibromatosis is inactivated in neurinoma and meningioma].
Sanson M
Rev Neurol (Paris); 1996 Jan; 152(1):1-10. PubMed ID: 8729390
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization and expression pattern of the neurofibromatosis type 2 protein merlin/schwannomin.
Schmucker B; Ballhausen WG; Kressel M
Eur J Cell Biol; 1997 Jan; 72(1):46-53. PubMed ID: 9013725
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants.
Wellenreuther R; Waha A; Vogel Y; Lenartz D; Schramm J; Wiestler OD; von Deimling A
Lab Invest; 1997 Dec; 77(6):601-6. PubMed ID: 9426397
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the NF2 tumor suppressor in Schwann cells is mediated by Cdc42-Pak and requires paxillin binding.
Thaxton C; Lopera J; Bott M; Baldwin ME; Kalidas P; Fernandez-Valle C
Mol Cell Neurosci; 2007 Feb; 34(2):231-42. PubMed ID: 17175165
[TBL] [Abstract][Full Text] [Related]
16. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
Chen Y; Gutmann DH; Haipek CA; Martinsen BJ; Bronner-Fraser M; Krull CE
Dev Dyn; 2004 Mar; 229(3):541-54. PubMed ID: 14991710
[TBL] [Abstract][Full Text] [Related]
17. The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors.
Ben-Ze'ev A
Electrophoresis; 1996 Nov; 17(11):1752-63. PubMed ID: 8982608
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of schwannomin/merlin in human sporadic meningiomas.
Lee JH; Sundaram V; Stein DJ; Kinney SE; Stacey DW; Golubić M
Neurosurgery; 1997 Mar; 40(3):578-87. PubMed ID: 9055299
[TBL] [Abstract][Full Text] [Related]
19. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
[TBL] [Abstract][Full Text] [Related]
20. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
Rouleau GA; Merel P; Lutchman M; Sanson M; Zucman J; Marineau C; Hoang-Xuan K; Demczuk S; Desmaze C; Plougastel B
Nature; 1993 Jun; 363(6429):515-21. PubMed ID: 8379998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]